• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[两种用于从血液样本和血培养瓶中检测布鲁氏菌的商用DNA提取试剂盒和PCR预混液的比较]

[Comparison of two commercial DNA extraction kits and PCR master mixes for the detection of Brucella from blood samples and blood culture bottles].

作者信息

Dal Tuba, Açıkgöz Ziya Cibali, Başyiğit Tuğcan, Zeybek Hasan, Durmaz Rıza

机构信息

Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey.

出版信息

Mikrobiyol Bul. 2018 Apr;52(2):135-146. doi: 10.5578/mb.66742.

DOI:10.5578/mb.66742
PMID:29933731
Abstract

The diagnosis of human brucellosis requires culture or serological tests for the conformation of the clinical findings. Isolation of the bacteria is used as a gold standard, however it is time consuming and processing of positive cultures has a potential risk for laboratory acquired human brucellosis. Polymerase chain reaction (PCR) based methods have offered new approaches for early diagnosis of brucellosis and reduce the risk of laboratory acquired human brucellosis. A major limitation of the PCR method is the difficulty to remove the inhibitors in specimens. The aim of this study was to determine the performance of two DNA extraction kits by using two separate PCR master mixes and to determine appropriate "extraction kit - PCR master mix" combination for the diagnosis of Brucella from whole blood samples and blood culture bottles. Two commercial DNA extraction kits, NORGEN Blood DNA isolation kit (Norgen) and Thermo Scientific GeneJet Whole blood genomic DNA purification kit (Thermo Fisher Scientific, USA) and two PCR master mixes, QuantiTect multiplex PCR (QuentiTect, Qiager, Almanya) and Ampliqon Multiplex TEMPase (Amliqon, Denmark) were assessed on 30 simulated blood samples with known concentrations (102-104 cfu/ml) of Brucella melitensis ATCC 23456 strain and 10 blood culture bottles that gave positive signal. By using different combinations of extraction kits and PCR master mixes, a total of 160 different multiplex real-time PCR (Rt-PCR) trials were performed with probes and primers specific to Brucella spp., B.melitensis, and the internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH). All the 120 Rt-PCR trials performed on the DNA samples extracted from blood samples gave positive results with GAPDH probe/primers. The rate of positive PCR results for Brucella spp. was 96.7% for the combination of Norgen-QuantiTect, 93.3% for Thermo-Ampliqon, 93.3% for Thermo-QuantiTect, and 86.7% for Norgen-Ampliqon. The frequency of positive B.melitensis results for these combinations were 96.7%, 93.3%, 56.7% and 90%, respectively. In the samples with the bacterial density of 102 cfu/ml, Brucella spp. detection rates were 80% for Thermo-Ampliqon and Norgen-Ampliqon, and 90% for Thermo-QuantiTect and Norgen-QuantiTect; and for B.melitensis positivite rates were 90%, 70%, 20%, and 90%, respectively. Rt-PCR assays with the DNA samples extracted from blood culture bottles using Norgen isolation kit yielded 80% positivite result. However, the frequency of PCR positivite results was only 20% in the DNA samples extracted by Thermo DNA extraction kit. PCR result for GAPDH gene was also negative in 80% of the samples extracted by Thermo kit. Our results revealed that for the removal of inhibitors and detection of even low number of Brucella spp./B.melitensis in blood samples and blood culture bottles, NORGEN Blood DNA isolation kit can be used with a combination of QuantiTect multiplex PCR or Ampliqon Multiplex TEMPase.

摘要

人类布鲁氏菌病的诊断需要进行培养或血清学检测以证实临床发现。细菌分离被用作金标准,然而这耗时较长,且对阳性培养物的处理存在实验室获得性人类布鲁氏菌病的潜在风险。基于聚合酶链反应(PCR)的方法为布鲁氏菌病的早期诊断提供了新途径,并降低了实验室获得性人类布鲁氏菌病的风险。PCR方法的一个主要局限性是难以去除标本中的抑制剂。本研究的目的是通过使用两种不同的PCR预混液来确定两种DNA提取试剂盒的性能,并确定用于从全血样本和血培养瓶中诊断布鲁氏菌的合适“提取试剂盒 - PCR预混液”组合。评估了两种商业DNA提取试剂盒,即NORGEN血液DNA分离试剂盒(Norgen)和赛默飞世尔科技的GeneJet全血基因组DNA纯化试剂盒(美国赛默飞世尔科技),以及两种PCR预混液,即QuantiTect多重PCR(QuentiTect,Qiagen,德国)和Ampliqon多重TEMPase(Amliqon,丹麦),对30份已知浓度(10² - 10⁴ cfu/ml)的流产布鲁氏菌ATCC 23456菌株模拟血样和10份呈阳性信号的血培养瓶进行检测。通过使用提取试剂盒和PCR预混液的不同组合,共进行了160次不同的多重实时PCR(Rt-PCR)试验,使用了针对布鲁氏菌属、流产布鲁氏菌以及内参甘油醛-3-磷酸脱氢酶(GAPDH)的探针和引物。对从血样中提取的DNA样本进行的所有120次Rt-PCR试验,使用GAPDH探针/引物均得到阳性结果。对于布鲁氏菌属,Norgen - QuantiTect组合的PCR阳性率为96.7%,Thermo - Ampliqon为93.3%,Thermo - QuantiTect为93.3%,Norgen - Ampliqon为86.7%。这些组合的流产布鲁氏菌阳性结果频率分别为96.7%、93.3%、56.7%和90%。在细菌密度为10² cfu/ml的样本中,Thermo - Ampliqon和Norgen - Ampliqon的布鲁氏菌属检测率为80%,Thermo - QuantiTect和Norgen - QuantiTect为90%;流产布鲁氏菌的阳性率分别为90%、70%、20%和90%。使用Norgen分离试剂盒从血培养瓶中提取的DNA样本进行Rt-PCR检测,阳性结果率为80%。然而,使用赛默飞DNA提取试剂盒提取的DNA样本中,PCR阳性结果频率仅为20%。赛默试剂盒提取的样本中,80%的样本GAPDH基因的PCR结果也为阴性。我们的结果表明,为了去除抑制剂并检测血样和血培养瓶中即使数量很少的布鲁氏菌属/流产布鲁氏菌,NORGEN血液DNA分离试剂盒可与QuantiTect多重PCR或Ampliqon多重TEMPase组合使用。

相似文献

1
[Comparison of two commercial DNA extraction kits and PCR master mixes for the detection of Brucella from blood samples and blood culture bottles].[两种用于从血液样本和血培养瓶中检测布鲁氏菌的商用DNA提取试剂盒和PCR预混液的比较]
Mikrobiyol Bul. 2018 Apr;52(2):135-146. doi: 10.5578/mb.66742.
2
Optimization and validation of a real-time polymerase chain reaction protocol for the diagnosis of human brucellosis.优化和验证实时聚合酶链反应协议在人布鲁氏菌病诊断中的应用。
Folia Microbiol (Praha). 2020 Apr;65(2):353-361. doi: 10.1007/s12223-019-00731-1. Epub 2019 Jul 31.
3
Multi-platform comparison of ten commercial master mixes for probe-based real-time polymerase chain reaction detection of bioterrorism threat agents for surge preparedness.基于探针的实时聚合酶链反应检测生物恐怖威胁因子的十种商业主混合物的多平台比较,以应对激增的准备。
Forensic Sci Int. 2012 Nov 30;223(1-3):292-7. doi: 10.1016/j.forsciint.2012.10.003. Epub 2012 Oct 26.
4
Comparison of seven commercial DNA extraction kits for the recovery of Brucella DNA from spiked human serum samples using real-time PCR.使用实时聚合酶链反应比较七种用于从加标的人血清样本中提取布鲁氏菌DNA的商用DNA提取试剂盒。
Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):109-14. doi: 10.1007/s10096-007-0409-y. Epub 2007 Nov 1.
5
Evaluation of automated and manual commercial DNA extraction methods for recovery of Brucella DNA from suspensions and spiked swabs.评估自动化和手动商业 DNA 提取方法从悬浮液和涂抹拭子中回收布鲁氏菌 DNA 的效果。
J Clin Microbiol. 2009 Dec;47(12):3920-6. doi: 10.1128/JCM.01288-09. Epub 2009 Oct 21.
6
Comparison of three different PCR methods for detection of Brucella spp in human blood samples.三种不同聚合酶链反应方法检测人血样本中布鲁氏菌属的比较
FEMS Immunol Med Microbiol. 2002 Oct 11;34(2):147-51. doi: 10.1111/j.1574-695X.2002.tb00616.x.
7
Comparison of multiplex real-time polymerase chain reaction with serological tests and culture for diagnosing human brucellosis.多重实时聚合酶链反应与血清学试验和培养比较诊断人类布鲁氏菌病。
J Infect Public Health. 2019 May-Jun;12(3):337-342. doi: 10.1016/j.jiph.2018.11.008. Epub 2018 Dec 13.
8
Molecular detection of Brucella species in patients suspicious of Brucellosis from Zanjan, Iran.对来自伊朗赞詹疑似布鲁氏菌病患者的布鲁氏菌属进行分子检测。
Braz J Microbiol. 2014 Aug 29;45(2):533-8. doi: 10.1590/s1517-83822014005000048. eCollection 2014.
9
Comparison of culture and PCR for the detection of Brucella melitensis in blood and lymphoid tissues of serologically positive and negative slaughtered sheep.比较培养法和聚合酶链反应法检测血清学阳性和阴性屠宰绵羊血液及淋巴组织中布鲁氏菌的情况。
Lett Appl Microbiol. 2008 Mar;46(3):301-6. doi: 10.1111/j.1472-765X.2007.02309.x. Epub 2007 Dec 20.
10
Molecular study of Brucellosis in camels by the use of TaqMan® real-time PCR.利用TaqMan®实时荧光定量PCR技术对骆驼布鲁氏菌病进行分子研究。
Acta Microbiol Immunol Hung. 2015 Dec;62(4):409-21. doi: 10.1556/030.62.2015.4.6.

引用本文的文献

1
Analysis of laboratory and serological test results in patients with acute brucellosis during follow-up.分析随访急性布鲁氏菌病患者的实验室和血清学检测结果。
J Clin Lab Anal. 2022 Mar;36(3):e24205. doi: 10.1002/jcla.24205. Epub 2022 Feb 9.
2
Optimization and validation of a real-time polymerase chain reaction protocol for the diagnosis of human brucellosis.优化和验证实时聚合酶链反应协议在人布鲁氏菌病诊断中的应用。
Folia Microbiol (Praha). 2020 Apr;65(2):353-361. doi: 10.1007/s12223-019-00731-1. Epub 2019 Jul 31.